These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18007688)

  • 1. Highlights from the report of the working group on "Core measures of the burden of skin diseases".
    VanBeek M; Beach S; Braslow L; Braslow JB; Chen SC; Chren MM; Margolis D; Chamlin S; Torrance G; Hodgson T
    J Invest Dermatol; 2007 Dec; 127(12):2701-6. PubMed ID: 18007688
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermatology quality of life instruments: sorting out the quagmire.
    Chen SC
    J Invest Dermatol; 2007 Dec; 127(12):2695-6. PubMed ID: 18007683
    [No Abstract]   [Full Text] [Related]  

  • 3. A catalog of dermatology utilities: a measure of the burden of skin diseases.
    Chen SC; Bayoumi AM; Soon SL; Aftergut K; Cruz P; Sexton SA; McCall CO; Goldstein MK
    J Investig Dermatol Symp Proc; 2004 Mar; 9(2):160-8. PubMed ID: 15083784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical review of generic and dermatology-specific health-related quality of life instruments.
    Both H; Essink-Bot ML; Busschbach J; Nijsten T
    J Invest Dermatol; 2007 Dec; 127(12):2726-39. PubMed ID: 17989733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of skin disease: quality of life, economic aspects and social issues.
    Finlay AY
    Clin Med (Lond); 2009 Dec; 9(6):592-4. PubMed ID: 20095308
    [No Abstract]   [Full Text] [Related]  

  • 6. [Assessment of quality of life in dermatology].
    Augustin M; Amon U; Braathen L; Bullinger M; Gieler U; Klein GF; Schultz-Amlung W
    J Dtsch Dermatol Ges; 2004 Sep; 2(9):802-6. PubMed ID: 16279226
    [No Abstract]   [Full Text] [Related]  

  • 7. Need and greed in dermatology: disease and outcome measures in dermatological healthcare planning.
    Dalgard F; Finlay AY
    Dermatology; 2006; 213(4):279-83. PubMed ID: 17135732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Therapy in Impairing Quality of Life in Dermatological Patients: A Multinational Study.
    Balieva FN; Finlay AY; Kupfer J; Aragones LT; Lien L; Gieler U; Poot F; Jemec GBE; Misery L; Kemeny L; Sampogna F; van Middendorp H; Halvorsen JA; Ternowitz T; Szepietowski JC; Potekaev N; Marron SE; Altunay IK; Salek SS; Dalgard FJ
    Acta Derm Venereol; 2018 Jun; 98(6):563-569. PubMed ID: 29507999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Psychosocial Burden of Skin Conditions and Symptoms: Measuring the Attributable Fraction.
    Sampogna F; Tabolli S; Giannantoni P; Paradisi A; Abeni D
    Acta Derm Venereol; 2016 Jan; 96(1):60-3. PubMed ID: 25766753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10 years experience of the Dermatology Life Quality Index (DLQI).
    Lewis V; Finlay AY
    J Investig Dermatol Symp Proc; 2004 Mar; 9(2):169-80. PubMed ID: 15083785
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality of life - an essential parameter for dermatology.
    Ring J
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):573. PubMed ID: 28425598
    [No Abstract]   [Full Text] [Related]  

  • 12. The psychological impact of living with skin disease.
    Clark A
    Prof Nurse; 2003 Aug; 18(12):689. PubMed ID: 12955940
    [No Abstract]   [Full Text] [Related]  

  • 13. Impairment of Sexual Life in 3,485 Dermatological Outpatients From a Multicentre Study in 13 European Countries.
    Sampogna F; Abeni D; Gieler U; Tomas-Aragones L; Lien L; Titeca G; Jemec GB; Misery L; Szabó C; Linder MD; Evers AW; Halvorsen JA; Balieva F; Szepietowski JC; Romanov DV; Marron SE; Altunay IK; Finlay AY; Salek SS; Kupfer J; Dalgard F
    Acta Derm Venereol; 2017 Apr; 97(4):478-482. PubMed ID: 27819713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quimp: A Word Meaning "Quality of Life Impairment".
    Finlay AY
    Acta Derm Venereol; 2017 Apr; 97(4):546-547. PubMed ID: 28303279
    [No Abstract]   [Full Text] [Related]  

  • 15. Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of Life.
    Finlay AY; Salek MS; Abeni D; Tomás-Aragonés L; van Cranenburgh OD; Evers AW; Jemec GB; Linder D; Manolache L; Marrón SE; Prinsen CA; Susitaival P; Chernyshov PV;
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):424-431. PubMed ID: 27684717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new psycho-dermatology clinic in Israel: our first year experience].
    Orion E; Ben-Avi O
    Harefuah; 2011 Jan; 150(1):9-12, 70. PubMed ID: 21449148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatology over the rainbow.
    Sebaratnam DF; Minocha R; Fernández-Peñas P
    JAMA Dermatol; 2015 May; 151(5):543. PubMed ID: 25671508
    [No Abstract]   [Full Text] [Related]  

  • 18. Report on "Burden of Skin Disease" Workshop. NIAMS, September 2002.
    Qureshi AA; Freedberg I; Goldsmith L; Moshell A
    J Investig Dermatol Symp Proc; 2004 Mar; 9(2):111-9. PubMed ID: 15083776
    [No Abstract]   [Full Text] [Related]  

  • 19. A risk adjustment approach to estimating the burden of skin disease in the United States.
    Lim HW; Collins SAB; Resneck JS; Bolognia J; Hodge JA; Rohrer TA; Van Beek MJ; Margolis DJ; Sober AJ; Weinstock MA; Nerenz DR; Begolka WS; Moyano JV
    J Am Acad Dermatol; 2018 Jan; 78(1):129-140. PubMed ID: 29110889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing "best available" medical options when practicing complex medical dermatology in resource-limited settings.
    Asemota E; Slaught C; Micheletti R; Kovarik C
    J Am Acad Dermatol; 2016 Oct; 75(4):e171-e172. PubMed ID: 27646770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.